Tebipenem's approval in 2026 under SPA could bring Spero $400M+ in milestones & royalties. Read more on why SPRO is a Buy, ...

Shares of GSK PLC GSK inched up 0.96% to £15.23 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.13% to 8,864.35. GSK ...

The release of Pretty Hurts comes two years after GSK collaborated with Lifetime on a short film highlighting the risks ...

Advent, a leading global private equity investor, today announced that funds managed by Advent have signed a definitive agreement to invest USD $175 million via primary and secondary for a significant ...